GlobeNewswire 09/01 BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 21/12/2023 BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Can...
GlobeNewswire 18/12/2023 BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
GlobeNewswire 12/12/2023 BioNTech to Inaugurate First African Site on December 18, 2023
GlobeNewswire 09/11/2023 Major Shareholder Announcement
GlobeNewswire 08/11/2023 Major Shareholder Announcement
GlobeNewswire 07/11/2023 Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
GlobeNewswire 07/11/2023 Genmab Announces Financial Results for the First Nine Months of 2023
GlobeNewswire 06/11/2023 BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
GlobeNewswire 26/10/2023 Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Agains...
GlobeNewswire 23/10/2023 BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advance...
GlobeNewswire 23/10/2023 BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to ...
GlobeNewswire 19/10/2023 BioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial wit...
GlobeNewswire 17/10/2023 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2023
GlobeNewswire 16/10/2023 BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023
GlobeNewswire 16/10/2023 Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs
GlobeNewswire 11/10/2023 Oxford BioTherapeutics Relocates UK Headquarters to Strategic and Cutting-Edge R&D Location at The O...
GlobeNewswire 28/09/2023 Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vac...
GlobeNewswire 25/09/2023 Genmab Announces European Commission Approval of TEPKINLY® (epcoritamab) for Adults with Relapsed or...
GlobeNewswire 18/09/2023 BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 1...
GlobeNewswire 15/09/2023 Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable...
GlobeNewswire 04/09/2023 Genmab and Seagen Announce That TIVDAK® (tisotumab vedotin-tftv) Met its Primary Endpoint of Improve...
GlobeNewswire 30/08/2023 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in th...
GlobeNewswire 15/03/2022 Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of the...
GlobeNewswire 08/03/2022 BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and ...